Captor Therapeutics ®
News
April 09, 2021
Successful initial public offering of Captor Therapeutics S.A.
March 23, 2021
Captor Therapeutics S.A. rozpoczyna ofertę publiczną akcji (IPO)
March 15, 2021
Captor Therapeutics S.A. is set to conduct a public offering
March 01, 2021
Paweł Dobrzański, PhD, joins Captor Therapeutics S.A. as Biology Department Director
January 20, 2021
Tom Shepherd as Chief Executive Officer
December 22, 2020
Captor Therapeutics and Sosei Heptares Enter Strategic Collaboration
October 22, 2020
Captor Therapeutics as one of the „Scrip’s 10 To Watch”
April 24, 2020
A new project in the area of autoimmune diseases